Dermamedics
DermaMedics develops novel, botanically-derived topical drugs for skin care, treating inflammation and aging without side effects.
Founded
2010DermaMedics develops novel, botanically-derived topical drugs for skin care, treating inflammation and aging without side effects.
Founded with a mission to revolutionize dermatology, DermaMedics specializes in developing botanically-derived topical therapeutics aimed at treating inflammatory skin conditions and aging. The company leverages its extensive expertise in skin research, drug discovery, and product formulation to create effective treatments without the side effects commonly associated with corticosteroids and immunosuppressive drugs. DermaMedics offers a range of products, including DermaRad Relief, Skin Tone Brightener, and various serums, targeting consumers seeking gentle yet effective skin care solutions.
DermaMedics has garnered attention for its innovative approach to skin care, attracting notable investors and industry experts. The company's research-driven methodology has led to significant advancements in topical therapeutics, earning it a reputable position in the dermatology market. With a commitment to safety and efficacy, DermaMedics continues to impact the field by providing alternatives that prioritize skin health without compromising on results.
Companies similar to Dermamedics include DermApproved, DermBiont, Dermaliq Therapeutics and Skin Pharm.
Dermamedics was founded in 2010.
Dermamedics' headquarters is located in Oklahoma City, OK, US.
Dermamedics' most recent funding round was for $1.5M (USD) in April 2012.
As of Apr 3, 2012, Dermamedics has raised a total of $1.5M (USD).
Dermamedics has 30 employees as of Feb 5, 2024.
Dermaliq Therapeutics
dermaliq.com
